logo
welcome
CNBC

CNBC

Health

Health

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

CNBC
Summary
Nutrition label

81% Informative

Semaglutide is the active ingredient in Novo Nordisk's weight loss drugs Wegovy and Ozempic .

Demand for the GLP-1s has exploded in recent years .

Digital health companies like Hims & Hers have been prescribing compounded medications.

The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days .

VR Score

77

Informative language

76

Neutral language

22

Article tone

formal

Language

English

Language complexity

57

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links